Abstract:Background Liver interstitial dendritic cells (DCs) have been implicated in the control of liver ischemia/reperfusion injury (IRI) and in the induction of liver transplant tolerance. However, mechanisms underlying these regulatory functions of liver DCs remain unclear. We have shown previously that the transmembrane adaptor protein DNAX-activating protein of 12 kDa (DAP12) is a negative regulator of mouse DC maturation. In this study, we focused on the role of DAP12 and its associated triggering receptor, triggering receptor expressed on myeloid cells 2 (TREM2) in the regulation of both mouse and human liver DC function and the role of DAP12 in regulation of liver IRI. Materials and Methods DAP12, TREM2, NFkB and T cell co-stimulatory or co-inhibitory molecule expression by freshly-isolated B6 mouse or normal human liver DCs was determined by flow cytometry, image stream and RT-PCR analysis. T cell proliferative responses were determined by CFSE-MLR and cytokine production by cytokine bead array analysis. DAP12-/- mice were bred from pairs provided by Dr. Marco Colonna, Washington University School of Medicine. Wild-type (WT) C57BL/6 (B6) and TREM2-/- mice were purchased from The Jackson Laboratory. Liver warm IRI was induced in DAP12-/- or WT mice by 1 hour 70% clamp. Liver enzyme (ALT) levels, inflammatory cytokine production and liver injury were quantified following 6 hours reperfusion. Results Both DAP12 and TREM2 were expressed at comparatively high levels by mouse and human liver DCs, while flow analysis revealed co-expression of DAP12 and TREM2 by 75+/- 3.5 % of human liver DCs. Mouse DCs lacking DAP12 or TREM2 exhibited increased levels of NFkB activation, co-stimulatory molecule expression, proinflammatory cytokine production and T cell stimulatory function. Silencing DAP12 expression in human liver DCs using siRNA also led to enhanced T cell stimulatory activity. Notably, unlike normal control WT liver DCs, DAP12-/- liver DCs failed to inhibit T cell proliferative responses to aCD3/CD28 stimulation. In vivo, DAP12-/- mice subjected to liver IRI exhibited enhanced liver injury, accompanied by evidence of enhanced liver DC activation. Conclusions Our data reveal a close association between the expression of DAP12 and its triggering receptor TREM2 by murine and human liver DC. DAP12 negatively regulates liver DC function and promotes their ability to inhibit inflammatory responses. Absence of DAP12 results in augmented liver IRI associated with enhanced liver DC activation. National Institute of Health grant R56 AI126377 (to AWT).National Institute of Health grant R01 HL 130191 (to AEM).

TREM2 protects against inflammation by regulating the release of mito-DAMPs from hepatocytes during liver fibrosis

The innate immune receptor TREM-1 promotes liver injury and fibrosis

Myeloid Trem2 Dynamically Regulates the Induction and Resolution of Hepatic Ischemia-Reperfusion Injury Inflammation

Function of TREM1 and TREM2 in Liver-Related Diseases

Triggering Receptor Expressed on Myeloid Cells-2 (TREM-2) Elicited by Lung Cancer Cells to Facilitate Tumor Immune Evasion.

TREM2 Insufficiency Protects against Pulmonary Fibrosis by Inhibiting M2 Macrophage Polarization

Biological and Clinical Role of TREM2 in Liver Diseases

Activation of triggering receptor expressed on myeloid cells-1 protects monocyte from apoptosis through regulation of myeloid cell leukemia-1.

Lipid-associated macrophages' promotion of fibrosis resolution during MASH regression requires TREM2

Myeloid Trem2 Ameliorates the Progression of Metabolic Dysfunction-Associated Steatotic Liver Disease by Regulating Macrophage Pyroptosis and Inflammation Resolution

Inhibition of TREM‐1 attenuates inflammation and lipid accumulation in diet‐induced nonalcoholic fatty liver disease

Myeloid Trem2 Orchestrates Nonalcoholic Steatohepatitis-Associated Inflammation and HCC Progression by Reprogramming Recruited Macrophages

Effect of triggering receptor expressed on myeloid cells 2-associated alterations on lipid metabolism in macrophages in the development of non-alcoholic fatty liver disease

TREM2 Activation Attenuates Neuroinflammation and Neuronal Apoptosis Via PI3K/Akt Pathway after Intracerebral Hemorrhage in Mice.

Inhibition of Triggering Receptor Expressed on Myeloid Cells 1 Ameliorates Inflammation and Macrophage and Neutrophil Activation in Alcoholic Liver Disease in Mice

TREM-1, an Inflammatory Modulator, is Expressed in Hepatocellular Carcinoma Cells and Significantly Promotes Tumor Progression

TREM2 regulates obesity-induced insulin resistance via adipose tissue remodeling in mice of high-fat feeding

Expression of DAP12 and Its Triggering Co-Receptor TREM2 Plays a Key Role in Regulation of Liver DC Function and Control of Liver Ischemia-Reperfusion Injury

Blockade of TREM2 ameliorates pulmonary inflammation and fibrosis by modulating sphingolipid metabolism

TREM2 deficiency aggravates renal injury by promoting macrophage apoptosis and polarization via the JAK-STAT pathway in mice

Soluble TREM2 levels reflect the recruitment and expansion of TREM2+ macrophages that localize to fibrotic areas and limit NASH